Fundraising Fox

Modulus Therapeutics

Seattle, US · Founded 2020 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

BR
Bryce R DainesNamed on SEC filing
MC
Max C DarnellNamed on SEC filing

Investors · 2

Madrona Venture GroupSeattle · $2M – $10M
KdT VenturesreportedAustin · $500K – $3M

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 1 round · 2021

▶$3.8MraisedJul 2021 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bryce R DainesExecutive Officer, Director
  • Max C DarnellExecutive Officer, Director
Offering amount
$3.8M
Amount sold
$3.8M
Minimum investment
$125K
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

AI2 Incubator spinout Modulus sells cell therapy tech assets to Boston's Ginkgo Bioworks – GeekWiregeekwire.com · Apr 2024Modulus Therapeutics Secures $3.5 Million in Seed Funding Roundhealthcaretechoutlook.com · Nov 2021Startup Modulus embraces AI to design better NK cell therapies for cancer - MedCity Newsmedcitynews.com · Sep 2021Modulus Therapeutics Secures Funding, Looks to Expand Cell Therapy Design Platform - Unite.AIunite.ai · Jul 2021Modulus, a cell therapy biotech incubated at the Allen Institute for AI, raises $3.5M – GeekWiregeekwire.com · Jul 2021

Frequently asked questions

Who are Modulus Therapeutics's investors?
Modulus Therapeutics's investors include Madrona Venture Group, KdT Ventures.
How much funding has Modulus Therapeutics raised?
Modulus Therapeutics has disclosed $3.8M raised across 1 round.
Where is Modulus Therapeutics headquartered?
Modulus Therapeutics is headquartered in Seattle, US.